Diana J. Schreier

Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin

Diana J. Schreier, Kianoush Kashani, Ankit Sakhuja et al. · Clinical Infectious Diseases · 2018 · 76 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method

Matthew P. Gray, Erin F. Barreto, Diana J. Schreier et al. · Drug Safety · 2022 · 41 citations · Full text

Nursing, Nephrology, Pharmacology +15

The high-value pharmacy enterprise framework: Advancing pharmacy practice in health systems through a consensus-based, strategic approach

Steve Rough, Rita Shane, John A. Armitstead et al. · American Journal of Health-System Pharmacy · 2021 · 33 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +17

Patterns of Cystatin C Uptake and Use Across and Within Hospitals

Hilary R. Teaford, Andrew D. Rule, Kristin C. Mara et al. · Mayo Clinic Proceedings · 2020 · 27 citations · Full text

Pharmacy, Clinical Pharmacy, Chemotherapy +4

Incidence and Predictive Factors Associated with Beta-Lactam Neurotoxicity in the Critically Ill: A Retrospective Cohort Study

Natalie A. Haddad, Diana J. Schreier, Jennifer E. Fugate et al. · Neurocritical Care · 2022 · 19 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13